A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis
R M Auchter(University of Wisconsin–Madison), Minesh P. Mehta(Columbia University), John P. Lamond, Allan B. Levin, William Noyes, Timothy J. Kinsella(Brown University), Jay S. Loeffler(Brigham and Women's Hospital), Eben Alexander, William A. Friedman, Christopher J. Schultz(Medical College of Wisconsin), Rick Chappell, John M. Buatti(University of Iowa)
International Journal of Radiation Oncology*Biology*Physics
April 1, 1996
Cited by 535
Related Papers
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2004|3.2k
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05
|International Journal of Radiation Oncology*Biology*Physics|2000|1.6k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k